Retinoic acid signaling through PI 3-kinase induces differentiation of human endometrial adenocarcinoma cells

Experimental and Molecular Pathology

Volumn 75, Issue 1, 2003, Pages 34-44

  Carter, Charleata A ^a  

^a Research Division   (United States)

Author keywords

Cancer; Cytoskeletal; Differentiation; Endometrium; F actin; PI 3 kinase; Retinoic acid receptor; Retinoids

Indexed keywords

PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE; PROTEIN KINASE PI 3; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR BETA; UNCLASSIFIED DRUG; WORTMANNIN;

ACTIN FILAMENT; ARTICLE; CANCER CELL CULTURE; CANCER MODEL; CELL DIFFERENTIATION; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; ENDOMETRIUM CARCINOMA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HYPERTROPHY; SIGNAL TRANSDUCTION; STAINING; WESTERN BLOTTING;

EID: 0038354962     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4800(03)00033-9     Document Type: Article

References (73)

1. Ai Z., Misra S., Susa M., Varticovski L., Cohan C.M. Phosphatidylinositol 3-kinase activity in murine erythroleukemia cells during DMSO-induced differentiation. Exp. Cell Res. 219:1995;454-460.
2. Bertagnolo V., Neri L.M., Marchisio M., Mischiati C., Capitani S. Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res. 59:1999;542-546.
3. Budd G.T., Adamson P.C., Gupta M., Homayoun P., Sandstrom S.K., Murphy R.F., McLain D., Tuason L., Peereboom D., Ganapathi R.D. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clin. Cancer Res. 4:1998;635-642.
4. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 376:1995;599-602.
5. Cantley L.C. The phosphoinositide 3-kinase pathway. Science. 296:2002;1655-1657.
6. Carpenter C.L., Cantley L.C. Phosphoinositide kinases. Curr. Opin. Cell Biol. 8:1996;153-158.
7. Carpenter C.L., Tolias K.F., Couvillon A.C., Hartwig J.H. Signal transduction pathways involving the small G proteins rac and Cdc42 and phosphoinositide kinases. Adv. Enzyme Regul. 37:1997;377-390.
8. Carter C.A., Rinehart C.A., Bagnell C.R., Kaufman D.G. Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the EJ ras oncogene. Pathobiology. 59:1991;36-45.
9. Carter C.A., Pogribny M., Davidson A., Jackson C.D., McGarrity L.J., Morris S.M. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells. Anticancer Res. 16:1996;17-24.
10. Carter C.A., Parham G.P. State of differentiation affects the response of endometrial adenocarcinoma cells to retinoic acid. Anticancer Res. 17:1997;1973-1984.
11. Carter C.A., Parham G.P., Chambers T.C. Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-α Pathobiology. 66:1998;284-292.
12. Carter C.A., Bellido T. Decrease in protein tyrosine phosphorylation is associated with F-actin reorganization by retinoic acid in human endometrial adenocarcinoma (RL95-2) cells. J. Cell. Phys. 178:1999;320-332.
13. Carter C.A. Protein kinase C as a drug target implications for drug or diet prevention and treatment of cancer . Curr. Drug Targets. 1:2000;163-183.
14. Carter C.A., Madden V. A newly characterized human endometrial adenocarcinoma cell line (CAC-1) differentiates in response to retinoic acid treatment. Exp. Mol. Pathol. 69:2000;175-191.
15. Carter C.A., Shaw B.L. Retinoic acid affects the EGF-R signaling pathway during differentiation induction of human endometrial adenocarcinoma cells. Exp. Mol. Pathol. 68:2000;170-186.
16. Cho Y., Klein M.G., Talmage D.A. Distinct functions of protein kinase C α and protein kinase C β during retinoic acid-induced differentiation of F9 cells. Cell Growth Differ. 9:1998;147-154.
17. Chou M.M., Hou W., Johnson J., Graham L.K., Lee M.H., Chen C.S., Newton A.C., Schaffhausen B.S., Toker A. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr. Biol. 8:1998;1069-1077.
18. Danowski B.A., Harris A.K. Changes in fibroblast contractility, morphology, and adhesion in response to a phorbol ester tumor promoter. Exp. Cell Res. 177:1988;47-59.
19. DeLuca L.M. Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J. 5:1991;2924-2933.
20. De Palo G., Camerini T., Marubini E., Costa A., Formelli F., Del Vecchio M., Mariani L., Micele R., Mascotti G., Magni A., Campa T., Di Mauro M.G., Attili A., Maltoni C., Del Turco M.R., Decensi A., D'Aiuto G., Veronesi U. Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual. Tumori. 83:1997;884-894.
21. Dion L.D., DeLuca L.M., Colburn N.H. Phorbol ester-induced anchorage independence and its antagonism by retinoic acid correlates with altered expression of specific glycoproteins. Carcinogenesis. 2:1981;951-958.
22. Eberle M., Traynor-Kaplan A.E., Sklar L.A., Norgauer J. Is there a relationship between phosphatidylinositol triphosphate and F-actin polymerization in human neutrophils. J. Biol. Chem. 265:1990;16725-16728.
23. Formelli F., Barua A.B., Olson J.A. Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl β-glucuronide. FASEB J. 10:1996;1014-1024.
24. Gómez J., Garcia A., R-Borlado L., Bonay P., Martinez-A C., Siva A., Fresno M., Carrera A.C., Eicher-Streiber C., Rebollo A. IL-2 signaling controls actin organization through Rho-like protein family, phosphatidylinositol 3-kinase, and protein kinase C-zeta. J. Immunol. 158:1997;1516-1522.
25. Goodman M.T., Wilkens L.R., Hankin J.H., Lyu L.-C., Wu A.H., Kolone L.N. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol. 146:1997;294-306.
26. Greenlee R.T., Murray T., Bolden S., Wingo P.A. Cancer Statistics, 2000. CA Cancer J. Clin. 50:2000;7-33.
27. Gundimeda U., Hara S.K., Anderson W.B., Gopalakrishna R. Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. Arch. Biochem. Biophys. 300:1993;526-530.
28. Hong W.K., Itri L.M. Retinoids and human cancer. Sporn M.B., Roberts A.B., Goodman D.S. The Retinoids Biology, Chemistry, and Medicine . 2nd ed. 1994;Raven Press, New York.
29. Hoyos B., Imam A., Chua R., Swenson C., Tong G.-X., Levi E., Noy N., Hammerling U. The cysteine-rich regions of the regulatory domains of raf and protein kinase C as retinoid receptors. J. Exp. Med. 192:2000;835-845.
30. Isakov N., Gopas J., Priel E., Segal S., Altman A. Effect of protein kinase C activating tumor promotors on metastases formation by fibrosarcoma cells. Invasion Metastasis. 11:1991;14-24.
31. Janmey P.A. Phosphoinositides and calcium as regulators of cellular actin assembly and disassembly. Annu. Rev. Physiol. 56:1994;169-191.
32. Jetten A., Deluca L. Studies on antagonistic actions of TPA and retinoic acid. Carcinogenesis. 7:1982;513-520.
33. Kapellar R., Cantley L.C. Phosphatidylinositol 3-kinase. Bioessays. 16:1994;565-576.
34. Khayat Z.A., Tong P., Yaworsky K., Blocj R.J., Klip A. Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT 4 in L6 myotubes. J. Cell Sci. 113:2000;279-290.
35. Khwaja A., Rodriguez-Viciana P., Wennström S., Warne P.H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO. J. 16:1997;2783-2793.
36. Kudelka A.P., Freedman R.S., Edwards C.L., Lippman S.M., Tornos C.S., Krakoff I.H., Kavanagh J.J. Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-α Anti-Cancer Drugs. 4:1993;335-337.
37. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.G., Williams L.T., Zetter B.R. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature. 367:1994;474-476.
38. Leevers S.J., Vanhaesebroeck B., Waterfield M.D. Signaling through phosphoinositide 3-kinases the lipids take centre stage . Curr. Opin. Cell Biol. 11:1999;219-225.
39. Lehtonen E., Lehto V.-P., Badley R.A., Virtanen I. Formation of vinculin plaques precedes other cytoskeletal changes during retinoic acid-induced teratocarcinoma cell differentiation. Exp. Cell Res. 144:1983;191-197.
40. Levi F., Franceschi S., Negri E., La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer. 71:1993;3575-3581.
41. Linseman D.A., Sorensen S.D., Fisher S.K. Attenuation of focal adhesion kinase signaling following depletion of agonist-sensitive pools of phosphatidylinositol 4,5-biphosphate. J. Neurochem. 73:1999;1933-1944.
42. Liu Q., Ning W., Dantzer R., Freund G.G., Kelley K.W. Activation of protein kinase C-ζ and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-1. J. Immunol. 160:1998;1393-1401.
43. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 10:1996;1031-1039.
44. Nadal A., Diaz M., Valverde M.A. The estrogen trinity membrane, cytosolic, and nuclear effects . News Physiol. Sci. 16:2001;251-255.
45. Nason-Burchenal K., Dmitrovsky E. The retinoids cancer therapy and prevention mechanisms . Nau H., Blaner W.S. Retinoids Handbook of Experimental Pharmacology . Vol. 139:1999;Springer-Verlag, Berlin.
46. Negri E., Vacchia C.L., Franceschi S., Levi F., Parazzini F. Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer. 77:1996;917-923.
47. Nobes C.D., Hall A. Rho, Rac and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell. 81:1995;53-62.
48. O'Brian C., Vogel V., Singletary S., Ward E. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49:1989;3215-3217.
49. Pienta K.J., Partin A.W., Coffey D.S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Res. 49:1989;2525-2532.
50. Powell C.T., Gschwend J.E., Fair W.R., Brittis N.J., Stec D., Huryk R. Overexpression of protein kinase C-zeta (PKC-ζ) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res. 56:1996;4137-4141.
51. Radominska-Pandya A., Chen G., Czernik P.J., Little J.M., Samokyszyn V.M., Carter C.A., Nowak G. Direct interaction of all-trans-retinoic acid with protein kinase C implications for PKC signaling and cancer therapy . J. Biol. Chem. 275:2000;22324-22330.
52. Rankin S., Hooshmand-Rad R., Claesson-Welsh L., Rozengurt E. Requirement for phosphatidylinositol 3′-kinase activity in platelet-derived growth factor-stimulated tyrosine phosphorylation of p125 focal adhesion kinase and paxillin. J. Biol. Chem. 271:1996;7829-7834.
53. Rao J.Y., Hurst R.E., Bales W.D., Jones P.L., Bass R.A., Archer L.T., Bell P.B., Hemstreet G.P. Cellular F-actin levels as a marker for cellular transformation relationship to cell division and differentiation . Cancer Res. 50:1990;2215-2220.
54. Reif K., Nobes C.D., Thomas G., Hall A., Cantrell D.A. Phosphatidylinositol 3-kinase signals activate a selective subset if Rac/Rho-dependent effector pathways. Curr. Biol. 6:1996;1445-1455.
55. Rose P.G. Endometrial carcinoma. N. Engl. J. Med. 335:1996;640-649.
56. Roymans D., Slegers H. Phosphatidylinositol 3-kinases in tumor progression. Eur. J. Biochem. 268:2001;487-498.
57. Rubin M., Fenig E., Rosenauer A., Menendez-Botet C., Achkar C., Bentel J.M., Yahalom J., Mendelsohn J., Miller W.H. Jr. 9-cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. Cancer Res. 54:1994;6549-6556.
58. Shepherd P.R., Withers D.J., Siddle K. Phosphoinositide 3-kinase the key switch mechanism in insulin signaling . Biochem J. 333:1998;471-490.
59. Siddiqui N.A., Thomas E.J., Dunlop W., Redfern C.P. Retinoic acid receptors and retinoid binding proteins in endometrial adenocarcinoma differential expression of cellular retinoid binding proteins in endometroid tumours . Int. J. Cancer. 64:1995;253-263.
60. Soltoff S.P., Rabin S.L., Cantley L.C., Kaplan D.R. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J. Bio. Chem. 267:1992;17472-17477.
61. Spinella M.J., Dmitrovsky E. Aberrant retinoid signaling and breast cancer the view from outside the nucleus J . Natl. Cancer Inst. 92:2000;438-440.
62. Takenawa T., Itoh T. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane. Biochim. Biophys. Acta. 1533:2001;190-206.
63. Toma S., Raffo P., Nicolo G., Canavese G., Margallo E., Vecchio C., Dastoli G., Iacona I., Regazzi-Bonora M. Biological activity of all-trans-retinoic acid with and without tamoxifen and alpha-interferon 2a in breast cancer patients. Int. J. Oncol. 17:2000;991-1000.
64. Tornus C., Elvio S. Pathology and grading of endometrial adenocarcinomas. Clin. Consultations Obstet. Gynecol. 5:1993;87-95.
65. Torrisi R., Decensi A., Formelli F., Camerini T., De Palo G. Chemoprevention of breast cancer with fenretinide. Drugs. 61:2001;909-918.
66. Tsai E.M., Wang S.C., Lee J.N., Hung M.C. Akt activation in estrogen receptor-negative breast cancer cells. Cancer Res. 61:2001;8390-8392.
67. Underwood B.A. Vitamin A in animal and human nutrition. Sporn M.B., Roberts A.B., Goodman D.S. The Retinoids. Vol 1:1984;Academic Press, London.
68. Wennström S., Hawkins P., Cooke F., Hara K., Yonezawa K., Kasuga M., Jackson T., Claesson-Welsh L., Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4:1994;385-393.
69. Xu X.C., Lee J.S., Lee J.J., Morice R.C., Liu X., Lippman S.M., Hong W.K., Lotan R. Nuclear retinoic acid receptor beta in bronchial epithelium of smokers before and during chemoprevention. J. Natl. Cancer Inst. 91:1999;1317-1321.
70. Zhang J., Fry M.J., Waterfield M.D., Jaken S., Liao L., Fox J.E.B., Ritterhouse S.E. Activated phosphoinositide 3-kinase associated with membrane skeleton in thrombin-exposed platelets. J. Biol. Chem. 267:1992;4686-4692.
71. Zhang D., Holmes W.F., Wu S., Soprano D.R., Soprano K.J. Retinoids and ovarian cancer. J. Cell Physiol. 185:2000;1-20.
72. Zheng W.L., Sierra-Rivera E., Luan J., Osteen K.G., Ong D.E. Retinoic acid synthesis and expression of cellular retinol-binding protein and cellular retinoic acid-binding protein type II are concurrent with decidualization of rat uterine stromal cells. Endocrinology. 141:2000;802-808.
73. Zou C.P., Hong W.K., Lotan R. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells. Differentiation. 64:1999;123-132.